Recent Finacing
Recent Raise
Switch Therapeutics is a preclinical biotech developing CASi conditionally activated siRNA molecules that integrate nucleic-acid nanotechnology with RNAi for self-delivery, cell-selective activation, and CNS-targeted programs.
